Navigation Links
Gerri Henwood Joins Actinium Pharmaceuticals as Chief Development Officer
Date:9/12/2012

NEW YORK, Sept. 12, 2012 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (API) announced today that Geraldine Henwood, an experienced biopharmaceutical executive, joined the Company's management team in the consultative capacity of Chief Development Officer, Iomab-B.  Ms. Henwood will spearhead efforts on further development of its clinical stage Iomab-B drug candidate.  Iomab-B is a monoclonal antibody construct in-licensed by API from Fred Hutchinson Cancer Research Center in Seattle.  It is indicated for bone marrow conditioning aimed at enabling hematopoietic stem cell transplantations (HSCT). 

"This is a great opportunity to move forward with a product that has already been in more than 250 patients in a series of Phase I and II clinical trials," said Ms. Henwood.  "We hope to progress this drug candidate into a pivotal study, and bring it to patients who otherwise have very few if any options."

Gerri Henwood brings with her a track record of successful drug development, both on the corporate side and organizing and monitoring clinical trials for clients.  She was the co-founder and CEO of Auxilium Pharmaceuticals, Inc. and the founder of IBAH, a major clinical research organization (CRO).  She also held senior positions at SmithKline Beecham.

"Over her career in the pharmaceutical industry, Ms. Henwood has built successful companies and has worked on a number of drugs that were approved and successfully launched. Her expertise is an important asset for our company," said Jack Talley, Actinium's CEO.

Ms. Henwood currently serves on the Board of Directors of Alkermes, Inc., MAP Pharmaceuticals, Inc. and is a member of the Board of Trustees for LaSalle Academy, an elementary school for "at risk" youth, in Philadelphia, PA

About Iomab-B

Iomab-B is a radioimmunoconjugate consisting of BC8, a novel murine monoclonal antibody, and iodine 131 radioisotope.  BC8 ha
'/>"/>

SOURCE Actinium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Robert G. Savage, Former Worldwide Chairman, Johnson & Johnsons Pharmaceuticals Group, Joins Board of Nuovo Biologics, LLC
2. Jeffrey Wasserstein Joins Greenhill as Managing Director Focused on the Pharmaceutical Sector
3. Gerald E. Quirk Joins Choate, Hall & Stewart LLP as Co-Chair of Life Sciences Group
4. Dr. Magnus Persson Joins Cerecors Board of Directors
5. Joseph Rogers Joins SRI International as Executive Director of New Health Sciences Section in Biosciences Division
6. Pharmacy Industry Veteran Joins Millennium Pharmacy Systems as SVP Operations
7. Biotechnology Thought Leader, Dr. Abbie Celniker, Joins ImaginAb Board of Directors as Chairman
8. Dr. Gerald Yakatan Joins Imprimis Pharmaceuticals Science and Regulatory Advisory Board
9. MinuteClinic Joins with American Heart Association to Help Americans Reduce High Blood Pressure
10. Stephen G. Austin, CPA Joins Imprimis Pharmaceuticals Board Of Directors
11. Remedy Informatics Joins LongView International Technology Solutions Team to Win CIO-SP3 Contract Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 2014 Statistics released from a number of ... astronomically during the holidays, beginning with Thanksgiving eve, which ... The data, highlighted in an Infographic ... part of their annual Sober Days for the ... high-risk drinking and increased rates of DUI injuries and ...
(Date:11/22/2014)... , Nov. 21, 2014 Many power ... the growing influence of patients in the biopharmaceutical ... interactions. Now, more than ever, understanding how to ... medical products is essential. According ... LLC, benchmarked companies spent about two-thirds of their ...
(Date:11/21/2014)... , Nov. 21, 2014  Tandem Diabetes ... ), a medical device company and manufacturer of ... a partnership with Tidepool, a non-profit dedicated to ... source software platform that increases diabetes data accessibility. ... Platform, which is currently under development, to download ...
Breaking Medicine Technology:Alarming Stats Show Holiday Drinking an Issue for Many 2New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3
... July 20, 2011 One of Frantz Medical Group,s ... it has been awarded an Ohio Third Frontier grant ... system for penetrating through vascular Chronic Total Occlusions (CTOs), ... Coronary Artery Bypass Graft (CABG).   VasoStar,s ...
... VEGAS, July 20, 2011 Cardinal Health today announced ... national trade show for independent pharmacies, is the largest ... attendees. This year,s event, taking place ... Palazzo resort hotel, features a 100,000-square-foot trade show floor, ...
Cached Medicine Technology:Frantz Medical Group Subsidiary, VasoStar, Awarded $1 Million Research Grant 2Frantz Medical Group Subsidiary, VasoStar, Awarded $1 Million Research Grant 3Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 2Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 3Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 4
(Date:11/23/2014)... “BlackVue” was featured on NewsWatch as part ... the latest and coolest technology products available to consumers. ... conducted the product review and shared with viewers how ... the car camera industry. , The need for in-car ... to find the one that’s right per consumer, especially ...
(Date:11/23/2014)... 23, 2014 BambooFlooringChina.com , the world’s ... click strand woven bamboo flooring collection. Now, the business ... the company’s CEO, the promotion is valid until Dec. 20, ... with a smooth and dust-free surface, which makes it very ... the industry, the company wants to make its website the ...
(Date:11/22/2014)... 2014 Cancer researchers in New York ... intercellular communication tunnels and the growth and spread of ... on the Surviving Mesothelioma website. , Doctors ... of Minnesota have just released their study on tunneling ... between cells. They found that mesothelioma cells ...
(Date:11/22/2014)... Recently, Locks-Magnetic.com , one of the ... of mag locks for glass doors online. In addition, ... these fresh products. Customers can get more information on ... are in excellent performance. Customers who want to buy ... as possible. They also can enjoy the one-stop ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 “Due to my ... an inventor, from Gurnee, Ill. “While using the ice grip ... and I thought there needed to be a safer way ... the SPIKE BLOCK. , The SPIKE BLOCK offers added safety ... it would help to reduce injuries and damage associated with ...
Breaking Medicine News(10 mins):Health News:A Leader in Front and Rear Facing In-Car Cameras was Featured on NewsWatch Television on October 30, 2014 2Health News:Click Strand Woven Bamboo Flooring From Famous Bamboo Flooring Company BambooFlooringChina.com 2Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:Discounted Mag Locks for Glass Doors Revealed by Locks-Magnetic.com 2
... ... Therapy of Cancer (iSBTc), the U.S. Food and Drug Administration approval of Dendreon,s ... advance in the development of biological therapy (also called immunotherapy) for cancer treatment. ... as active cellular immunotherapies. , ...
... A team of researchers at the University of Georgia ... five years from the National Institutes of Health to study ... drug abuse relapse. "Drug abuse is closely linked ... treating addiction is preventing the relapse caused by stress," said ...
... ... alcohol regulations to keep them safe, according to a new poll conducted by a bipartisan ... showed that 75% of adults support “the rights of individual states to set their own ... ...
... approach lengthens survival, to varying degrees, for men with ... News) -- The U.S. Food and Drug Administration ... aimed at preventing the spread of prostate cancer in ... The new approval is limited to "the treatment of ...
... equal opportunity destroyer. It attacks the central nervous system ... victims are celebrated cellist Jacqueline du Pre, whose career was ... writers but they are far from alone. ... about 400,000 cases in the U.S. and more that 2 ...
... care, economic equality as reasons why , THURSDAY, April ... than Americans, likely due to the United States, lack ... and economic equality, a new study suggests. , U.S. ... of Health 2002-03 and found that Canadians can expect ...
Cached Medicine News:Health News:FDA Approval of new Prostate Treatment Shows Promise of Cancer Immunotherapy 2Health News:FDA Approval of new Prostate Treatment Shows Promise of Cancer Immunotherapy 3Health News:UGA, Emory to study how exercise may prevent drug abuse relapse 2Health News:Survey Finds Broad Support for Alcohol Regulations to Keep the Public Safe 2Health News:Prostate Cancer Vaccine Gains FDA Approval 2Health News:Prostate Cancer Vaccine Gains FDA Approval 3Health News:Catching multiple sclerosis before it strikes 2Health News:Catching multiple sclerosis before it strikes 3Health News:Canadians Leading Longer, Healthier Lives Than Americans 2
High sensitive, specific one step immunochromatographic assay for human infectious disease...
BioSign® Malaria - Rapid Malaria Antigen Test...
Paracheck Pf is a two site sandwich immunoassay for the detection of P. falciparum specific histidine rich protein 2 (Pf HRP-2) in whole blood samples....
DiaMed OptiMAL-IT is an immuno-chromatographic test, using monoclonal antibodies against the metabolic enzyme pLDH (parasite lactate dehydrogenase) of Plasmodium spp. These Mabs are classified in t...
Medicine Products: